Anavex Life Sciences Corp (AVXL)

[bas2020]

Seems you're neglecting some critical facts...
1. Blarcamesine trial patients were more advanced in disease state.
2. Blarcamesine reached the level of benefit nearly 7 months earlier than lecanemab (CDR-SB).
3. Psychoactive drugs take a bit of time before they become effective.

But keep trying to convince us otherwise.